July 18, 2017 | Israel’s Therapix Biosciences, a pharmaceutical company dedicated to the development of medicinal marijuana, has signed a memorandum of understanding (MOU) with CURE Pharmaceutical to enter a research collaboration with Assuta Medical Center, Israel’s largest private medical services center. The companies will collaborate to advance, research, develop and commercialize potential therapeutic products in the […]